Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 21;13(1):56.
doi: 10.1186/s13000-018-0733-9.

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases

Shirong Ma  1 , Linni Fan  1 , Yixiong Liu  1 , Yingmei Wang  1 , Kangjie Yu  2 , Lifeng Wang  3 , Na Fang  4 , Fang Liu  5 , Shuangping Guo  1 , Zhe Wang  6
Affiliations

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases

Shirong Ma et al. Diagn Pathol. .

Abstract

Background: Myxofibrosarcoma (MFS) is one of the most common soft tissue sarcomas. Previous studies have shown that MET protein overexpressed in MFS patients and can serve as a prognostic factor. The reasons for MET protein overexpression include amplification of the MET gene, which is located on chromosome 7q. Triggered by an index case harboring chromosome 7 polysomy rather than MET gene amplification in myxofibrosarcoma, we investigated chromosome 7 polysomy in more cases.

Methods: Immunohistochemistry and fluorescence in situ hybridization (FISH) were performed in 30 MFS cases (including 2 epithelioid variant) to detect the expression of MET protein and gene status.

Results: MET was overexpressed in 14 cases out of 30, while thirteen cases were in higher FNCLCC grades (Grade 2-3). FISH showed that 11 cases having 3 signals on average of Met and more than 3 signals (Mean: 4.6) of centromere 7q (CEP7q). The MET/CEP7 ratio was about 0.65 on average, suggesting that chromosome 7 polysomy, rather than Met gene amplification, leading to the overexpression of MET protein in MFS. MET overexpression and chromosome 7 polysomy are positively correlated with higher Ki-67 index and higher grade and might have a high risk of local recurrence and metastasis.

Conclusions: It might reveals another explain of MET overexpression in myxofibrosarcoma, providing a clue for the therapy of MFS.

Keywords: Chromosome 7 polysomy; FISH; MET; Myxofibrosarcoma.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study procedures were approved by the Ethics Committee of Xijing Hospital (reference numbe: KY-20171981). No consent was needed.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Mophology of MFS: Spindle to polygonal sarcoma cells within variably myxoid stroma containing long curvilinear vessels. a: FNCLCC Grade 1 MFS; b: FNCLCC Grade 2 MFS; c: FNCLCC Grade 3 MFS; d: Epithelioid variant of MFS, tumor cells is an infiltrative multinodular growth pattern, with alternation of hypercellular and hypocellular myxoid areas. Tumor cells had epithelioid morphology with abundant eosinophilic cytoplasm and oval or plump spindle nuclei, scattered in the myxoid background (inset).
Fig. 2
Fig. 2
MET immunostain shows positive cytoplasm staining in the FNCLCC Grade 2 (a), Grade 3 (b), and Epthelioid MFS (c), while negative expression in FNCLCC Grade 1 MFS (d)
Fig. 3
Fig. 3
FISH examination of met gene status by MET (red)/CEP 7(green). Chromosome 7 polysomy, rather than MET amplification, was found in FNCLCC Grade 2 cases (a), Grade 3 cases (b), and epithelioid variant (c). Lower FNCLCC grade cases are usually negative for either MET amplification or chromosome 7 polysomy (d)
See this image and copyright information in PMC

References

    1. Look Hong NJ, Hornicek FJ, Raskin KA, Yoon SS, Szymonifka J, Yeap B, et al. Prognostic factors and outcomes of patients with myxofibrosarcoma. Ann Surg Oncol. 2013;20(1):80–86. doi: 10.1245/s10434-012-2572-3. - DOI - PMC - PubMed
    1. Nascimento AF, Bertoni F, Fletcher CD. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol. 2007;31(1):99–105. doi: 10.1097/01.pas.0000213379.94547.e7. - DOI - PubMed
    1. Yang Y, Wu N, Shen J, Teixido C, Sun X, Lin Z, et al. MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer. Gastric Cancer. 2015; - PubMed
    1. Paliga A, Marginean H, Tessier-Cloutier B, Purgina B, Jonker D, Marginean EC. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas. American journal of clinical oncology. 2015; - PubMed
    1. Refaat T, Donnelly ED, Sachdev S, Parimi V, El Achy S, Dalal P, et al. C-met overexpression in cervical Cancer, a prognostic factor and a potential molecular therapeutic target. Am J Clin Oncol. 2015; - PMC - PubMed

MeSH terms

LinkOut - more resources